Latest Jagsonpal Pharmaceuticals stock price
Jagsonpal Pharmaceuticals P/E Ratio
JAGSNPHARM • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
22.7
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
22.7
Current Price
₹187.48
EPS (TTM)
₹8.26
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
57.32
Sector Median
35.38
Sector Rank
#11 of 89
Sector Percentile
12.4%
Key P/E Ratio Insights for Jagsonpal Pharmaceuticals
- Trading at discount to sector average PE of 57.32
View the JAGSNPHARM equity price for detailed stock performance.
Related Pages for Jagsonpal Pharmaceuticals
Additional stock information and data for JAGSNPHARM
Sector P/E Ratio Comparison
Comparing Jagsonpal Pharmaceuticals with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
89
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |